Carroll Jill's Form 4 filing
Avalyn Pharma Inc. (AVLN) · filed May 1, 2026
- Accession no.
- 0001193125-26-201894
- Filed
- May 1, 2026
- Trade date
- May 1, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $5.00M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carroll JillCIK 0001598542 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | CConversionAcquired | +1,419,298 | – | – | 1,419,298 | Indirect | |
| May 1, 2026 | Common Stock | CConversionAcquired | +489,486 | – | – | 1,908,784 | Indirect | |
| May 1, 2026 | Common Stock | PPurchaseAcquired | +277,778 | $18.00 | +$5,000,004 | 2,186,562 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | CConversionDisposed | −1,419,298 | – | – | 0 | Indirect | |
| May 1, 2026 | Common Stock | CConversionDisposed | −489,486 | – | – | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.